AG003CNR

104632-26-0 | (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

AG003CNR

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	104632-26-0
Catalog Number	AG003CNR(AGN-PC-0NVU9J)
Chemical Name	(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
EC Number	600-593-1
IUPAC Name	(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
InChI	InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1
InChI Key	FASDKYOPVNHBLU-ZETCQYMHSA-N
MDL Number	MFCD00869076
Molecular Formula	C10H17N3S
Molecular Weight	211.3271
SMILES	Nc1nc2c(s1)C[C@H](CC2)NCCC
UNII	83619PEU5T
Synonyms	2 Amino 6 propylaminotetrahydrobenzothiazole, 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole, 2-amino-6-propylaminotetrahydrobenzothiazole, 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine, 6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate, dexpramipexole, KNS 760704, KNS-760704, KNS760704, Mirapex, pramipexol, pramipexol dihydrobromide, (+-)-isomer, pramipexol dihydrochloride, (S)-isomer, pramipexol, (+-)-isomer, pramipexol, (R)-isomer, pramipexole, Pramipexole Dihydrochloride, Pramipexole Dihydrochloride Anhydrous, Pramipexole Hydrochloride Monohydrate, Sifrol, SND 919, SND 919CL2x, SND-919, SND-919CL2x, SND919CL2x, pramipexole, 104632-26-0, (-)-Pramipexole, Pramipexol, Sifrol, Mirapexin, Pramipexolum, (S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine, (S)-Pramipexole, Mirapex, U-98528E, SUD919CL2Y, Pramipexol [Spanish], Pramipexolum [Latin], SND 919, SND-919, UNII-83619PEU5T, (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole, CHEBI:8356, CHEMBL301265, (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, 83619PEU5T, 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-, NCGC00167441-01, Oprymea, 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-, (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, DSSTox_CID_3496, DSSTox_RID_77054, DSSTox_GSID_23496, 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6S)-, Pramipexole Teva, SND-919CL2Y, Pramipexole [USAN:INN], (S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole;(S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole, SMR000449298, CAS-104632-26-0, SR-01000763219, Pramipexole (USAN/INN), SUD 919CL2Y, Pramipexole [USAN:INN:BAN], 2-amino-6-propylaminotetrahydrobenzothiazole, Pramipexole Base, (-) Pramipexole, Pramipexole-Mirapex, 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole, Pramipexole (Mirapex), Spectrum_001838, 111GE001, SpecPlus_000820, Spectrum5_001453, EC 600-593-1, AC1L3P1T, SCHEMBL35376, GTPL953, KBioSS_002343, MLS000758250, MLS001423952, BIDD:GT0250, DivK1c_006916, SUD-919CL2Y, DTXSID6023496, CTK8C0068, HSDB 8253, KBio1_001860, KBio2_002340, KBio2_004908, KBio2_007476, FASDKYOPVNHBLU-ZETCQYMHSA-N, (s)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole, HMS2051A21, HMS2090C15, HMS2232B03, HY-B0410, KS-00000A3W, ZINC3781664, Tox21_112445, ANW-64032, BDBM50116766, CX1349, MFCD00869076, s2460, Tox21_112445_1, CCG-100823, CS-2510, DB00413, NC00073, NCGC00167441-02, NCGC00167441-03, AJ-45593, CPD000449298, DS-14807, LS-40722, SAM001247006, SC-46343, AB0055235, DB-038042, RT-015572, B1488, FT-0651622, ST24036373, SW197453-4, D05575, K-0425, AB00053772-12, AB00053772-13, AB00053772_14, AB00053772_16, 632P260, A801025, J-001211, SR-01000763219-5, SR-01000763219-6, 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperaziny, (6S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine, (6S)-N'-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, (s)-(-)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole, (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, sifrole, Dexpramipexole, Daquiran, Mirapexin (TN), Sifrol(TN), Mirapex (TN), PRAMIPEXOLE HCl, Pramipexole dihydrochloride, pramipexol dihydrobromide, pramipexol, (R)-isomer, pramipexol, (+-)-isomer, D0G8NN, SND919CL2x, SND 919CL2x, SND-919CL2x, C10H17N3S, PRAMIPEXOLE HYDROCHLORIDE, KNS-760704, Pramipexole hydrochloride hydrate, Pramipexole Dihydrochloride Anhydrous, Pramipexole Hydrochloride Monohydrate, C10-H17-N3-S, CID119570, KNS760704, Pramipexole dihydrochloride monohydrate, ACN-036084, CS-O-02206, KNS 760704, pramipexol dihydrochloride, (S)-isomer, pramipexol dihydrobromide, (+-)-isomer, 2 Amino 6 propylaminotetrahydrobenzothiazole, 2248B, (S)-N6-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine, C061333, D000077487, 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine, (6S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine, (s)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazolediamine, 191217-81-9, 6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate, 1649-18-9,

Complexity	188
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	211.114g/mol
Formal Charge	0
Heavy Atom Count	14
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	211.327g/mol
Monoisotopic Mass	211.114g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	79.2A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	1.9

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number